The global Drug Developing Platforms by Artificial Intelligence (AI) market size was valued at US$ million in 2023. With growing demand in downstream market, the Drug Developing Platforms by Artificial Intelligence (AI) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Drug Developing Platforms by Artificial Intelligence (AI) market. Drug Developing Platforms by Artificial Intelligence (AI) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Drug Developing Platforms by Artificial Intelligence (AI). 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Drug Developing Platforms by Artificial Intelligence (AI) market.
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Drug Developing Platforms by Artificial Intelligence (AI) market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Drug Developing Platforms by Artificial Intelligence (AI) market. It may include historical data, market segmentation by Type (e.g., Software, System), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Drug Developing Platforms by Artificial Intelligence (AI) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Drug Developing Platforms by Artificial Intelligence (AI) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Drug Developing Platforms by Artificial Intelligence (AI) industry. This include advancements in Drug Developing Platforms by Artificial Intelligence (AI) technology, Drug Developing Platforms by Artificial Intelligence (AI) new entrants, Drug Developing Platforms by Artificial Intelligence (AI) new investment, and other innovations that are shaping the future of Drug Developing Platforms by Artificial Intelligence (AI).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Drug Developing Platforms by Artificial Intelligence (AI) market. It includes factors influencing customer ' purchasing decisions, preferences for Drug Developing Platforms by Artificial Intelligence (AI) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Drug Developing Platforms by Artificial Intelligence (AI) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Drug Developing Platforms by Artificial Intelligence (AI) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Drug Developing Platforms by Artificial Intelligence (AI) market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Drug Developing Platforms by Artificial Intelligence (AI) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Drug Developing Platforms by Artificial Intelligence (AI) market.
麻豆原创 Segmentation:
Drug Developing Platforms by Artificial Intelligence (AI) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Software
System
Service
Product
Others
Segmentation by application
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
厂肠丑谤枚诲颈苍驳别
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size 2019-2030
2.1.2 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Developing Platforms by Artificial Intelligence (AI) Segment by Type
2.2.1 Software
2.2.2 System
2.2.3 Service
2.2.4 Product
2.2.5 Others
2.3 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Type
2.3.1 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Drug Developing Platforms by Artificial Intelligence (AI) Segment by Application
2.4.1 Generate Data and Models
2.4.2 Repurpose Existing Drugs
2.4.3 Generate Novel Drug Candidates
2.4.4 Validate and Optimize Drug Candidates
2.4.5 Design Drugs
2.4.6 Others
2.5 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Application
2.5.1 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Player
3.1 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue by Players (2019-2024)
3.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Developing Platforms by Artificial Intelligence (AI) by Regions
4.1 Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size Growth (2019-2024)
4.3 APAC Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size Growth (2019-2024)
4.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Country (2019-2024)
5.2 Americas Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Type (2019-2024)
5.3 Americas Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Region (2019-2024)
6.2 APAC Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Type (2019-2024)
6.3 APAC Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) by Country (2019-2024)
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Type (2019-2024)
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) by Region (2019-2024)
8.2 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Regions (2025-2030)
10.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Regions (2025-2030)
10.1.2 Americas Drug Developing Platforms by Artificial Intelligence (AI) Forecast
10.1.3 APAC Drug Developing Platforms by Artificial Intelligence (AI) Forecast
10.1.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Forecast
10.1.5 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Forecast
10.2 Americas Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Country (2025-2030)
10.2.1 United States Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.2.2 Canada Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.2.3 Mexico Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.2.4 Brazil Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3 APAC Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Region (2025-2030)
10.3.1 China Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3.2 Japan Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3.3 Korea Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3.4 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3.5 India Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.3.6 Australia Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Country (2025-2030)
10.4.1 Germany Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.4.2 France Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.4.3 UK Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.4.4 Italy Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.4.5 Russia Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.5 Middle East & Africa Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Region (2025-2030)
10.5.1 Egypt Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.5.2 South Africa Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.5.3 Israel Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.5.4 Turkey Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.5.5 GCC Countries Drug Developing Platforms by Artificial Intelligence (AI) 麻豆原创 Forecast
10.6 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Type (2025-2030)
10.7 Global Drug Developing Platforms by Artificial Intelligence (AI) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Antidote
11.1.1 Antidote Company Information
11.1.2 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Antidote Main Business Overview
11.1.5 Antidote Latest Developments
11.2 Atomwise
11.2.1 Atomwise Company Information
11.2.2 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.2.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Atomwise Main Business Overview
11.2.5 Atomwise Latest Developments
11.3 Turbine
11.3.1 Turbine Company Information
11.3.2 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.3.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Turbine Main Business Overview
11.3.5 Turbine Latest Developments
11.4 Cambridge Cancer Genomics
11.4.1 Cambridge Cancer Genomics Company Information
11.4.2 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.4.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Cambridge Cancer Genomics Main Business Overview
11.4.5 Cambridge Cancer Genomics Latest Developments
11.5 Row Analytics
11.5.1 Row Analytics Company Information
11.5.2 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.5.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Row Analytics Main Business Overview
11.5.5 Row Analytics Latest Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Information
11.6.2 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.6.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Deep Genomics Main Business Overview
11.6.5 Deep Genomics Latest Developments
11.7 Insilico Medicine
11.7.1 Insilico Medicine Company Information
11.7.2 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.7.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Insilico Medicine Main Business Overview
11.7.5 Insilico Medicine Latest Developments
11.8 IBM
11.8.1 IBM Company Information
11.8.2 IBM Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.8.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 IBM Main Business Overview
11.8.5 IBM Latest Developments
11.9 Microsoft
11.9.1 Microsoft Company Information
11.9.2 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.9.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Microsoft Main Business Overview
11.9.5 Microsoft Latest Developments
11.10 Google
11.10.1 Google Company Information
11.10.2 Google Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.10.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Google Main Business Overview
11.10.5 Google Latest Developments
11.11 AiCure
11.11.1 AiCure Company Information
11.11.2 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.11.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 AiCure Main Business Overview
11.11.5 AiCure Latest Developments
11.12 Calico
11.12.1 Calico Company Information
11.12.2 Calico Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.12.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Calico Main Business Overview
11.12.5 Calico Latest Developments
11.13 Iktos
11.13.1 Iktos Company Information
11.13.2 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.13.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Iktos Main Business Overview
11.13.5 Iktos Latest Developments
11.14 GNS Healthcare
11.14.1 GNS Healthcare Company Information
11.14.2 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.14.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 GNS Healthcare Main Business Overview
11.14.5 GNS Healthcare Latest Developments
11.15 Genpact
11.15.1 Genpact Company Information
11.15.2 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.15.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Genpact Main Business Overview
11.15.5 Genpact Latest Developments
11.16 Biovista
11.16.1 Biovista Company Information
11.16.2 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.16.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Biovista Main Business Overview
11.16.5 Biovista Latest Developments
11.17 NuMedii
11.17.1 NuMedii Company Information
11.17.2 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.17.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 NuMedii Main Business Overview
11.17.5 NuMedii Latest Developments
11.18 BenevolentAI
11.18.1 BenevolentAI Company Information
11.18.2 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.18.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 BenevolentAI Main Business Overview
11.18.5 BenevolentAI Latest Developments
11.19 BERG
11.19.1 BERG Company Information
11.19.2 BERG Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.19.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 BERG Main Business Overview
11.19.5 BERG Latest Developments
11.20 厂肠丑谤枚诲颈苍驳别
11.20.1 厂肠丑谤枚诲颈苍驳别 Company Information
11.20.2 厂肠丑谤枚诲颈苍驳别 Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.20.3 厂肠丑谤枚诲颈苍驳别 Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 厂肠丑谤枚诲颈苍驳别 Main Business Overview
11.20.5 厂肠丑谤枚诲颈苍驳别 Latest Developments
11.21 Nuritas
11.21.1 Nuritas Company Information
11.21.2 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.21.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.21.4 Nuritas Main Business Overview
11.21.5 Nuritas Latest Developments
11.22 Exscientia
11.22.1 Exscientia Company Information
11.22.2 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.22.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.22.4 Exscientia Main Business Overview
11.22.5 Exscientia Latest Developments
11.23 Kairntech
11.23.1 Kairntech Company Information
11.23.2 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.23.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.23.4 Kairntech Main Business Overview
11.23.5 Kairntech Latest Developments
11.24 Concerto HealthAI (SymphonyAI)
11.24.1 Concerto HealthAI (SymphonyAI) Company Information
11.24.2 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.24.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.24.4 Concerto HealthAI (SymphonyAI) Main Business Overview
11.24.5 Concerto HealthAI (SymphonyAI) Latest Developments
11.25 NVIDIA Corporation
11.25.1 NVIDIA Corporation Company Information
11.25.2 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.25.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.25.4 NVIDIA Corporation Main Business Overview
11.25.5 NVIDIA Corporation Latest Developments
11.26 Sirenas
11.26.1 Sirenas Company Information
11.26.2 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.26.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.26.4 Sirenas Main Business Overview
11.26.5 Sirenas Latest Developments
11.27 Standigm
11.27.1 Standigm Company Information
11.27.2 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.27.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.27.4 Standigm Main Business Overview
11.27.5 Standigm Latest Developments
11.28 Transcriptic
11.28.1 Transcriptic Company Information
11.28.2 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.28.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.28.4 Transcriptic Main Business Overview
11.28.5 Transcriptic Latest Developments
11.29 Cloud Pharmaceuticals
11.29.1 Cloud Pharmaceuticals Company Information
11.29.2 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.29.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.29.4 Cloud Pharmaceuticals Main Business Overview
11.29.5 Cloud Pharmaceuticals Latest Developments
11.30 Cyclica
11.30.1 Cyclica Company Information
11.30.2 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Product Offered
11.30.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.30.4 Cyclica Main Business Overview
11.30.5 Cyclica Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.